Macquarie Group LTD Trans Medics Group, Inc. Transaction History
Macquarie Group LTD
- $83.5 Billion
- Q3 2025
A detailed history of Macquarie Group LTD transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 906,268 shares of TMDX stock, worth $104 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
906,268
Previous 952,105
4.81%
Holding current value
$104 Million
Previous $128 Million
20.31%
% of portfolio
0.12%
Previous 0.16%
Shares
22 transactions
Others Institutions Holding TMDX
# of Institutions
438Shares Held
30.4MCall Options Held
1.03MPut Options Held
934K-
Vanguard Group Inc Valley Forge, PA3.61MShares$415 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$304 Million0.01% of portfolio
-
State Street Corp Boston, MA1.28MShares$147 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL1.07MShares$123 Million0.03% of portfolio
-
Ubs Group Ag856KShares$98.5 Million0.02% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.66B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...